E-LIB Suche - Ergebnisse für: Sandberg-Wollheim, M

1

Pathogenesis of Autoimmune Diseases: Antibodies Against Tra..:

Bodil Roth, E. ; Theander, E. ; Londos, E....
Scandinavian Journal of Immunology. 67 (2008) 6 - p. 626-631 , 2008

Link: https://doi.org/10.1111/..

2

Cognitive dysfunction 24–31 years after isolated optic neur..:

Nilsson, P ; Rorsman, I ; Larsson, EM..
Multiple Sclerosis Journal. 14 (2008) 7 - p. 913-918 , 2008

Link: https://doi.org/10.1177/..

3

Health-related quality of life in secondary progressive mul..:

Beiske, A.G. ; Naess, H. ; Aarseth, J.H....
Multiple Sclerosis Journal. 13 (2007) 3 - p. 386-392 , 2007

Link: https://doi.org/10.1177/..

4

A follow-up study of Nordic multiple sclerosis candidate ge..:

Datta, P. ; Harbo, H.F. ; Ryder, L.P....
Multiple Sclerosis Journal. 13 (2007) 5 - p. 584-589 , 2007

Link: https://doi.org/10.1177/..

5

Long-term subcutaneous interferon beta-1a therapy in patien..:

Kappos, L. ; Traboulsee, A. ; Constantinescu, C....
Neurology. 67 (2006) 6 - p. 944-953 , 2006

Link: https://doi.org/10.1212/..

6

Neutralizing antibodies and efficacy of interferon β-1a: A ..:

Kappos, L. ; Clanet, M. ; Sandberg-Wollheim, M....
Neurology. 65 (2005) 1 - p. 40-47 , 2005

Link: https://doi.org/10.1212/..

7

Pregnancy outcomes during treatment with interferon beta-1a..:

Sandberg-Wollheim, M. ; Frank, D. ; Goodwin, T. M....
Neurology. 65 (2005) 6 - p. 802-806 , 2005

Link: https://doi.org/10.1212/..

8

Treatment with laquinimod reduces development of active MRI..:

Polman, C. ; Barkhof, F. ; Sandberg-Wollheim, M....
Neurology. 64 (2005) 6 - p. 987-991 , 2005

Link: https://doi.org/10.1212/..

9

Comparative tolerance of IFN beta-1a regimens in patients w..:

Sandberg-Wollheim, M. ; Bever, C. ; Carter, J....
Journal of Neurology. 252 (2005) 1 - p. 8-13 , 2005

Link: https://doi.org/10.1007/..

10

No evidence for genetic linkage between development of mult..:

Bergkvist, M ; Olsson, M ; Sandberg-Wollheim, M
Multiple Sclerosis Journal. 10 (2004) 1 - p. 87-88 , 2004

Link: https://doi.org/10.1191/..

11

International consensus statement on the use of disease-mod..:

Freedman, MS ; Blumhardt, LD ; Brochet, B....
Multiple Sclerosis Journal. 8 (2002) 1_suppl - p. 19-23 , 2002

Link: https://doi.org/10.1177/..

12

A randomized, double-blind, dose-comparison study of weekly..:

Clanet, M. ; Radue, E.W. ; Kappos, L....
Neurology. 59 (2002) 10 - p. 1507-1517 , 2002

Link: https://doi.org/10.1212/..

13

International consensus statement on the use of disease-mod..:

Freedman, M S ; Blumhardt, L D ; Brochet, B...
Multiple Sclerosis Journal. 8 (2002) 1 - p. 19-23 , 2002

Link: https://doi.org/10.1191/..

14

Analysis of an interferon-γ gene dinucleotide-repeat polymo..:

Dai, Y. ; Masterman, T. ; Huang, W.X....
Multiple Sclerosis. 7 (2001) 3 - p. 157-163 , 2001

Link: https://doi.org/10.1191/..

15

Analysis of an interferon-γ gene dinucleotide-repeat polymo..:

Dai, Y ; Masterman, T ; Huang, W X...
Multiple Sclerosis Journal. 7 (2001) 3 - p. 157-163 , 2001

Link: https://doi.org/10.1177/..